Back to Search
Start Over
Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
- Source :
- Journal of the Formosan Medical Association, Vol 120, Iss 12, Pp 2186-2190 (2021), Journal of the Formosan Medical Association
- Publication Year :
- 2021
- Publisher :
- Elsevier, 2021.
-
Abstract
- We presented the clinical course and immune responses of a well-controlled HIV-positive patient with COVID-19. The clinical presentation and antibody production to SARS-CoV-2 were similar to other COVID-19 patients without HIV infection. Neutralizing antibody reached a plateau from 26th to 47th day onset but decreased on 157th day after symptoms.
- Subjects :
- Medicine (General)
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Human immunodeficiency virus (HIV)
Case Report
medicine.disease_cause
03 medical and health sciences
0302 clinical medicine
Immune system
R5-920
medicine
Neutralizing antibody
Coronavirus
biology
Plaque reduction assay
business.industry
Clinical course
Enzyme-linked immunosorbent assay (ELISA)
virus diseases
General Medicine
Positive patient
Antiretroviral therapy
Severe acute respiratory syndrome
030220 oncology & carcinogenesis
Immunology
biology.protein
030211 gastroenterology & hepatology
business
Subjects
Details
- Language :
- English
- ISSN :
- 09296646
- Volume :
- 120
- Issue :
- 12
- Database :
- OpenAIRE
- Journal :
- Journal of the Formosan Medical Association
- Accession number :
- edsair.doi.dedup.....b7d566de43db6f154ecbda41dccc923d